To explore the correlation of intolerance of uncertainty (IU) and emotion regulation (ER) in patients with generalized anxiety disorder (GAD), a total of 108 GAD patients and 115 healthy participants were recruited. The intolerance of uncertainty scale (IUS) was used to evaluate the level of IU. The emotion regulation questionnaire (ERQ) was used to evaluate participants’ preference for emotion regulation strategies. The Hamilton anxiety scale (HAMA) and generalized anxiety disorder scale (GAD-7) were used to assess the degree of anxiety symptoms. Spearman correlation analysis and linear regression analysis were performed on participants’ scores. The scores of the IUS subscales, ERQ subscales, and HAMA in the GAD group were different from those in healthy controls (HC group) (p ≤ 0.001). IUS subscales were correlated with ERQ subscales, and inhibitory IU was significantly correlated with expression suppression strategies (p < 0.01). The level of IU is correlated with the selection of emotion regulation strategies in patients with GAD. Moderating effect analysis shows that emotion regulation strategies partially moderate the relationship between IU level and anxiety symptoms. This study underscores the critical role of intolerance of uncertainty and emotion regulation in shaping anxiety severity in GAD, highlighting the potential for targeted interventions that address both cognitive and emotional dimensions.
Background: Anxiety disorders are highly prevalent yet lack objective biomarkers. Whereas threat-related attentional biases are well documented, less is known about broader eye movement alterations that may characterise anxiety. Aims: To characterise multi-paradigm eye movement profiles in anxiety disorders and evaluate their potential as behavioural markers for disorder differentiation. Method: Eye movements were recorded in 91 patients with anxiety disorders, 118 with depressive disorders and 98 healthy controls during free viewing of neutral-stimuli, smooth-pursuit and fixation-stability tasks. Principal component analysis was applied to derive latent eye movement dimensions, which were then tested for group differences, associations with symptom severity and classification performance. Results: Compared with both patients with depression and healthy controls, patients with anxiety disorders exhibited hyper-scanning during free viewing, characterised by increased saccade frequency and path length, and hyper-pursuit during smooth pursuit, reflected in increased velocity gain, fewer intrusive saccades and more catch-up saccades. Principal component analysis identified six latent components, among which active visual exploration, pupillary arousal and smooth-pursuit control demonstrated robust group differences. Machine learning models trained on 6 components yielded areas under the receiver operating characteristic curve of 0.82 for anxiety versus healthy controls, 0.83 for depression versus healthy controls and 0.61 for anxiety versus depression. Conclusions: Hyper-scanning and hyper-pursuit emerge as defining eye movement signatures of anxiety, linking core mechanisms of vigilance and prediction with measurable behavioural markers. These insights position eye-tracking as a promising behavioural modality for mechanism-informed differentiation across affective disorders.